CDTTW vs. ATNFW, SXTPW, DRTSW, WENAW, APLMW, BCTXW, CDIOW, CTCXW, CELUW, and CEROW
Should you be buying Conduit Pharmaceuticals stock or one of its competitors? The main competitors of Conduit Pharmaceuticals include 180 Life Sciences (ATNFW), 60 Degrees Pharmaceuticals (SXTPW), Alpha Tau Medical (DRTSW), Anew Medical (WENAW), Apollomics (APLMW), BriaCell Therapeutics (BCTXW), Cardio Diagnostics (CDIOW), Carmell (CTCXW), Celularity (CELUW), and CERo Therapeutics (CEROW). These companies are all part of the "biotechnology" industry.
Conduit Pharmaceuticals vs.
180 Life Sciences (NASDAQ:ATNFW) and Conduit Pharmaceuticals (NASDAQ:CDTTW) are both medical companies, but which is the better business? We will compare the two companies based on the strength of their analyst recommendations, risk, community ranking, earnings, profitability, dividends, valuation, institutional ownership and media sentiment.
180 Life Sciences and Conduit Pharmaceuticals both received 0 outperform votes by MarketBeat users.
In the previous week, 180 Life Sciences had 1 more articles in the media than Conduit Pharmaceuticals. MarketBeat recorded 1 mentions for 180 Life Sciences and 0 mentions for Conduit Pharmaceuticals. 180 Life Sciences' average media sentiment score of 0.59 beat Conduit Pharmaceuticals' score of 0.00 indicating that 180 Life Sciences is being referred to more favorably in the media.
Summary
180 Life Sciences beats Conduit Pharmaceuticals on 2 of the 2 factors compared between the two stocks.
Get Conduit Pharmaceuticals News Delivered to You Automatically
Sign up to receive the latest news and ratings for CDTTW and its competitors with MarketBeat's FREE daily newsletter.
New MarketBeat Followers Over Time
This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Media Sentiment Over Time
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
CDTTW vs. The Competition
Conduit Pharmaceuticals Competitors List
Related Companies and Tools
This page (NASDAQ:CDTTW) was last updated on 5/3/2025 by MarketBeat.com Staff
Buy CDTTW Stock Free CDTTW Stock Alerts